Ligand Pharmaceuticals (LGND) Selling, General & Administrative (2010 - 2026)

Ligand Pharmaceuticals (LGND) Selling, General & Administrative (2010 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	SG&A (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-10.08 Mn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	555.10 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-1.47 Mn
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	493.70 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	647.70 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	17.02 Mn
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	1.13 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	101.25 Mn
10	Ligand Pharmaceuticals	6.05 Bn	5.27 Bn	48.45 Mn	20.84 Mn

Download Data